Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
18.65
+0.89 (5.01%)
At close: Jul 2, 2026, 4:00 PM EDT
18.70
+0.05 (0.27%)
After-hours: Jul 2, 2026, 7:29 PM EDT
Relay Therapeutics Market Cap
Relay Therapeutics has a market cap or net worth of $4.06 billion as of July 2, 2026. Its market cap has increased by 674.77% in one year.
Market Cap
4.06B
Enterprise Value
3.45B
1-Year Change
674.77%
Ranking
Category
Stock Price
$18.65
Market Cap Chart
Since July 16, 2020, Relay Therapeutics's market cap has increased from $3.03B to $4.06B, an increase of 33.93%. That is a compound annual growth rate of 5.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 4.06B | 177.20% |
| Dec 31, 2025 | 1.47B | 112.63% |
| Dec 31, 2024 | 689.62M | -49.19% |
| Dec 29, 2023 | 1.36B | -24.86% |
| Dec 30, 2022 | 1.81B | -45.57% |
| Dec 31, 2021 | 3.32B | -11.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viking Therapeutics | 4.35B |
| Tango Therapeutics | 4.26B |
| Edgewise Therapeutics | 4.26B |
| Denali Therapeutics | 4.10B |
| NewAmsterdam Pharma Company | 4.07B |
| Telix Pharmaceuticals | 4.04B |
| Catalyst Pharmaceuticals | 3.85B |
| Arcus Biosciences | 3.81B |